276 related articles for article (PubMed ID: 17764181)
1. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
Teixidó M; Zurita E; Malakoutikhah M; Tarragó T; Giralt E
J Am Chem Soc; 2007 Sep; 129(38):11802-13. PubMed ID: 17764181
[TBL] [Abstract][Full Text] [Related]
2. Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.
Malakoutikhah M; Teixidó M; Giralt E
J Med Chem; 2008 Aug; 51(16):4881-9. PubMed ID: 18666771
[TBL] [Abstract][Full Text] [Related]
3. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification.
Guixer B; Arroyo X; Belda I; Sabidó E; Teixidó M; Giralt E
J Pept Sci; 2016 Sep; 22(9):577-91. PubMed ID: 27440580
[TBL] [Abstract][Full Text] [Related]
4. N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.
Malakoutikhah M; Prades R; Teixidó M; Giralt E
J Med Chem; 2010 Mar; 53(6):2354-63. PubMed ID: 20170117
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
6. Development of the blood-brain barrier.
Engelhardt B
Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
[TBL] [Abstract][Full Text] [Related]
7. [The blood-brain barrier. II. Physiological data (conclusion)].
Lefauconnier JM; Hauw JJ
Rev Neurol (Paris); 1984; 140(2):89-109. PubMed ID: 6143382
[TBL] [Abstract][Full Text] [Related]
8. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
9. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
10. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier.
Escuder-Gilabert L; Molero-Monfort M; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):193-201. PubMed ID: 15203029
[TBL] [Abstract][Full Text] [Related]
11. Lipid bilayer crossing--the gate of symmetry. Water-soluble phenylproline-based blood-brain barrier shuttles.
Arranz-Gibert P; Guixer B; Malakoutikhah M; Muttenthaler M; Guzmán F; Teixidó M; Giralt E
J Am Chem Soc; 2015 Jun; 137(23):7357-64. PubMed ID: 25992679
[TBL] [Abstract][Full Text] [Related]
12. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
13. Passive diffusion of acetylcholinesterase oxime reactivators through the blood-brain barrier: influence of molecular structure.
Karasova JZ; Pohanka M; Musilek K; Zemek F; Kuca K
Toxicol In Vitro; 2010 Sep; 24(6):1838-44. PubMed ID: 20546883
[TBL] [Abstract][Full Text] [Related]
14. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
Pardridge WM
Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
Pardridge WM
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier delivery.
Pardridge WM
Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
[TBL] [Abstract][Full Text] [Related]
17. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
[TBL] [Abstract][Full Text] [Related]
18. New diketopiperazines as vectors for peptide protection and brain delivery: Synthesis and biological evaluation.
Virgone-Carlotta A; Dufour E; Bacot S; Ahmadi M; Cornou M; Moni L; Garcia J; Chierici S; Garin D; Marti-Batlle D; Perret P; Ghersi-Egea JF; Moulin Sallanon M; Fagret D; Ghezzi C
J Labelled Comp Radiopharm; 2016 Oct; 59(12):517-530. PubMed ID: 27611733
[TBL] [Abstract][Full Text] [Related]
19. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
Nonaka N; Shioda S; Niehoff ML; Banks WA
J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
[TBL] [Abstract][Full Text] [Related]
20. Methods to assess drug permeability across the blood-brain barrier.
Nicolazzo JA; Charman SA; Charman WN
J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
